中文
Products

TORCH (5-in-1) IgG/IgM Antibody Test Kit

TORCH (5-in-1) IgG/IgM Antibody Test Kit (Quantum Dots)

Intended Use

For the in vitro quantitative detection of Cytomegalovirus (CMV) IgG/IgM Antibody, Rubella Virus (RV) IgG/IgM Antibody, Toxoplasma gondii (TOX) IgG/IgM Antibody, Herpes Simplex Virus Type Ⅰ (HSV-Ⅰ) IgG/IgM Antibody and Herpes Simplex Virus Type Ⅱ (HSV-Ⅱ) IgG/IgM Antibody in human serum, plasma, or whole blood samples.

TORCH (5-in-1) IgG/IgM Antibody Test Kit

Clinical Department

Clinical Laboratory, Paediatrics Department, Gastroenterology Department, Emergency Department, Infectious Diseases Department, Outpatient Department, etc.

Product Parameters Clinical application

[Product Name]TORCH (5-in-1) IgG/IgM Antibody Test Kit

[Sample Type]serum, plasma or whole blood

[Intended Use]
For the in vitro quantitative detection of Cytomegalovirus (CMV) IgG/IgM Antibody, Rubella Virus (RV) IgG/IgM Antibody, Toxoplasma gondii (TOX) IgG/IgM Antibody, Herpes Simplex Virus Type Ⅰ (HSV-Ⅰ) IgG/IgM Antibody and Herpes Simplex Virus Type Ⅱ (HSV-Ⅱ) IgG/IgM Antibody in human serum, plasma, or whole blood samples.

[Clinical Department]
Clinical Laboratory, Paediatrics Department, Gastroenterology Department, Emergency Department, Infectious Diseases Department, Outpatient Department, etc.


Product Parameters

Item

TORCH IgG/IgM Ab (Quantum Dots)

Test Time

15-20min

Sample Type

serum, plasma or whole blood

Sensitivity

/

Storage Condition

4-30℃

Packing Specification

1 Test/Kit; 2 Tests/Kit; 5 Tests/Kit; 10 Tests/Kit; 20 Tests/Kit; 40 Tests/Kit


CMV, RV, TOX, HSV-Ⅰ and HSV-Ⅱ are common pathogens responsible for perinatal infections, intrauterine fetal infections, and opportunistic infections in immunocompromised individuals. Infections can lead to severe consequences including miscarriage, stillbirth, fetal malformation, hearing impairment, neurological damage and severe neonatal infections, and are characterised by strong concealment and high pathogenicity.

1. Preconception screening to identify the pre-pregnancy infection status of women of childbearing age.

2. Antenatal monitoring to prevent and control the risk of fetal infection.

3. Assisting in the diagnosis of neonatal infections.

4. Differentiating infection stages to guide clinical treatment.


微信公众平台

官网二维码